ENVOY MEDICAL, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.62 USD | -5.07% |
|
-5.07% | +44.70% |
| May. 15 | Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000 | MT |
| May. 15 | Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | - | 35.4 | 46.45 | - | - |
| Enterprise Value (EV) 1 | - | 35.4 | 46.45 | 46.45 | 46.45 |
| P/E ratio | -77.1 x | - | - | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 112 x | 116 x | 133 x | 18.6 x |
| EV / Revenue | - | 112 x | 116 x | 133 x | 18.6 x |
| EV / EBITDA | - | -1.94 x | -2.11 x | -2.09 x | - |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | - | 19,550 | 19,600 | - | - |
| Reference price 2 | 10.02 | 1.811 | 2.370 | 2.370 | 2.370 |
| Announcement Date | 6/30/23 | 4/1/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.316 | 0.4 | 0.35 | 2.5 |
| EBITDA 1 | - | -18.24 | -22 | -22.2 | - |
| EBIT 1 | - | -18.37 | -20.7 | -20.7 | - |
| Operating Margin | - | -5,813.61% | -5,175% | -5,912.86% | - |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | -15.92 | - | - | - | - |
| Net margin | - | - | - | - | - |
| EPS | -0.1300 | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 6/30/23 | 4/1/24 | - | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|
| Net sales 1 | 0.095 | 0.059 | 0.1 | 0.1 | 0.1 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -6.735 | -4.898 | -5.1 | -5.2 | -5.5 |
| Operating Margin | -7,089.47% | -8,301.69% | -5,100% | -5,200% | -5,500% |
| Earnings before Tax (EBT) | -18.27 | - | - | - | - |
| Net income | -18.27 | - | - | - | - |
| Net margin | -19,233.68% | - | - | - | - |
| EPS | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/1/24 | 5/15/24 | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 6/30/23 | 4/1/24 | - | - | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.37
USD
Average target price
5.5
USD
Spread / Average Target
+132.07%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +44.70% | 46.45M | |
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.61B |
- Stock Market
- Equities
- COCH Stock
- Financials Envoy Medical, Inc.
